COVID-19 Blog

KOL Collaborators Present Microbix HPV Test-Control Results

KOL Collaborators Present Microbix HPV Test-Control Results

announces that it is presenting results of a novel Quality Assessment Product (“QAP™”) for supporting patient diagnosis and tissue analysis relating to infection with the Herpes Simplex Virus (“HSV”) at the European Meeting on Molecular Diagnostics (“EMMD”) taking place in Noordwijk, The Netherlands, October 9 to 11, 2024.

read more
Microbix Presents Novel HSV Test Control at EMMD

Microbix Presents Novel HSV Test Control at EMMD

announces that it is presenting results of a novel Quality Assessment Product (“QAP™”) for supporting patient diagnosis and tissue analysis relating to infection with the Herpes Simplex Virus (“HSV”) at the European Meeting on Molecular Diagnostics (“EMMD”) taking place in Noordwijk, The Netherlands, October 9 to 11, 2024.

read more
Microbix Presenting at Muskoka Capital Conference

Microbix Presenting at Muskoka Capital Conference

Microbix will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29, 2024.

read more
Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

Microbix Biosystems Inc. reports results for its third quarter and first nine months of fiscal 2024 ended June 30, 2024 (“Q3” and “YTD”) with strong revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices businesses and resulting in material net income for Q3 and YTD.

read more
Microbix Schedules Release of Results for Q3 Fiscal 2024

Microbix Schedules Release of Results for Q3 Fiscal 2024

Microbix Biosystems Inc. announces that it expects to file the financial statements and management disclosure and analysis for its third quarter of fiscal 2024 ended June 30, 2024 (“Q3 2024”) prior to the start of trading on August 14, 2024.

read more
Microbix Presents HCV FLOQSwab® Format Test Control at ADLM

Microbix Presents HCV FLOQSwab® Format Test Control at ADLM

Microbix Biosystems Inc. introduces a novel Quality Assessment Product (QAP™) for Hepatitis C Virus (HCV) POCTs at the ADLM conference. This swab-based, room-temperature stable control aims to enhance accessibility and accuracy of HCV testing, especially in low-resource settings.

read more
Microbix Hosts Minister Nina Tangri to Open Capacity Expansions

Microbix Hosts Minister Nina Tangri to Open Capacity Expansions

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, to celebrate the opening of two expansions to its medical devices manufacturing capacity at one of its three adjacent Mississauga sites.

read more